Mark Pellett

Executive Director and Section Head @阿斯利康

London, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2025 — Present

Executive Director and Section Head @阿斯利康

View department →

EDUCATION

1990 — 1991

Loughborough University

MSc, Theory and Application of Computation

1986 — 1989

Aston University

BSc, Pharmacy

1991 — 1994

Cardiff University / Prifysgol Caerdydd

PhD, Pharmaceutical Sciences

1979 — 1986

Woodbridge School

A Levels, Mathes, Chemistry and Biology

SKILLS

StrategyCmc RegulatoryCmcPharmaceutical ScientistPharmaceutical IndustryPharmaceutical DevelopmentProduct DevelopmentDue DiligenceRegulatory AffairsFormulation DevelopmentRegulationsDrug DeliveryFormulationDrug DevelopmentPhamacistConsumer Healthcare

ABOUT MARK PELLETT

A pharmacist with a PhD in topical and transdermal drug delivery, and an MSc in Information Technology. • Preparation of Regulatory CMC strategies and their execution for global markets. • Extensive management of contractors and generation of CMC data for licence applications. Developed CMC strategies, authored Modules 3’s and QOS’s, and successfully lead Agency meetings for both pre- and post-approval products.• Experienced in developing products including- Identification, evaluation and demonstration of proof of concept for new product opportunities- Leading global project teams in a matrix environment integrating the overall product development strategies for CMC, regulatory, clinical and delivering market claims.• Developed and launched a range of different formulations including soft gelatin capsules, tablets, syrups, effervescent tablets, topical gels and sprays, suspensions, and nasal sprays. • Successfully managed CPs, DCP\'s and MRPs from initiation to conclusion; multiple national filings and provided regulatory strategy for variations. • Managed teams of up to twelve members of staff, which involved coaching, mentoring, appraisals, managing projects and resources. • Leading a section of 60 members of staff providing and implementing creative regulatory CMC strategies for biologic programs and championing reliance and inter-agency collaborations.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Mark Pellett — Executive Director and Section Head at 阿斯利康 in London, GB | Unifers